AbbVie Declares Quarterly Dividend

Rhea-AI Summary

AbbVie (NYSE: ABBV) announced its board declared a quarterly cash dividend of $1.73 per share. The dividend is payable August 14, 2026, to shareholders of record on July 15, 2026. Since 2013, AbbVie has raised its dividend by over 330% and is part of the S&P Dividend Aristocrats Index.

AI-generated analysis. Not financial advice.

Positive

• Quarterly cash dividend of $1.73 per share declared
• Dividend payable on August 14, 2026
• Shareholders of record on July 15, 2026 qualify
• Dividend has increased by over 330% since 2013 inception
• Membership in S&P Dividend Aristocrats Index highlights long-term dividend growth record

Negative

• None.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH CHICAGO, Ill., June 18, 2026 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.73 per share. 

The cash dividend is payable August 14, 2026, to stockholders of record at the close of business on July 15, 2026.

Since the company's inception in 2013, AbbVie has increased its dividend by more than 330 percent. AbbVie is a member of the S&P Dividend Aristocrats Index, which tracks companies that have annually increased their dividend for at least 25 consecutive years.

About AbbVie

AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.

Media: Marianne Ostrogorski (224) 240-6336	Investors: Liz Shea (847) 935-2211
marianne.ostrogorski@abbvie.com	liz.shea@abbvie.com

 

View original content:https://www.prnewswire.com/news-releases/abbvie-declares-quarterly-dividend-302804858.html

SOURCE AbbVie

FAQ

What quarterly dividend did AbbVie (ABBV) declare on June 18, 2026?

AbbVie declared a quarterly cash dividend of $1.73 per share. According to AbbVie, this dividend continues its long-term focus on returning cash to shareholders while maintaining a record of significant dividend growth since the company’s inception in 2013.

When is the AbbVie (ABBV) dividend payment date for the $1.73 per share dividend?

The $1.73 per share AbbVie dividend is payable on August 14, 2026. According to AbbVie, shareholders who are on record by the July 15, 2026 record date will receive this quarterly cash dividend payment on the scheduled date.

What is the record date for AbbVie’s August 14, 2026 dividend payment (ABBV)?

The record date for AbbVie’s $1.73 per share dividend is July 15, 2026. According to AbbVie, investors must be stockholders of record at the close of business on that date to qualify for the August 14, 2026 dividend payment.

How much has AbbVie (ABBV) increased its dividend since 2013?

AbbVie reports it has increased its dividend by more than 330% since 2013. According to AbbVie, this growth in the dividend reflects its commitment to shareholder returns and supports its inclusion in the S&P Dividend Aristocrats Index of consistent dividend growers.

Is AbbVie (ABBV) part of the S&P Dividend Aristocrats Index?

Yes, AbbVie is a member of the S&P Dividend Aristocrats Index. According to AbbVie, this index tracks companies that have raised their dividend every year for at least 25 consecutive years, highlighting AbbVie’s consistent dividend growth profile for income-focused investors.